Author:
Kalisvaart Marit,de Jonge Jeroen
Publisher
Springer International Publishing
Reference30 articles.
1. Abdelaziz O, et al. Endovascular management of early hepatic artery thrombosis after living donor liver transplantation. Transpl Int. 2012;25(8):847–56.
https://doi.org/10.1111/j.1432-2277.2012.01509.x
.
2. Bohorquez H, et al. Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy. Am J Transplant. 2017;17(8):2155–64.
https://doi.org/10.1111/ajt.14261
.
3. Croome KP, et al. Improving national results in liver transplantation using grafts from donation after cardiac death donors. Transplantation. 2016;100(12):2640–7.
https://doi.org/10.1097/TP.0000000000001483
.
4. Croome KP, Taner CB. Are we moving from absence of proof to proof of absence? Liver Transpl. 2016;22(12):1635–6.
https://doi.org/10.1002/lt.24645
.
5. Eghtesad B, Hashimoto K, Watson M, Nazzal M, Quintini C, Kelly D, Diago T, Kawamura N, El-Gazzaz G, Fujiki M, Aucejo F, Winans C, Miller C, Fung J. Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial [abstract]. Am J Transplant. 2015;15(suppl 3).
https://atcmeetingabstracts.com/abstract/use-of-tissue-plasminogen-activator-tpa-in-liver-transplantation-from-donation-after-cardiac-death-dcddonors-a-controlled-randomized-trial/
. Accessed April 24, 2020.